| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |